Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders

Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on... Rationale Cigarette demand is a behavioral economic mea- ed in similar reductions in cigarette reinforcement. Larger ini- sure of the relative value of cigarettes. Decreasing the value tial reductions in demand on quit day were associated with of cigarette reinforcement may help with quitting smoking. early success with abstaining from cigarettes. Behavioral eco- Objectives This study aimed to evaluate the effects of initial nomic approaches may be useful for identifying individuals use of varenicline (VAR) versus nicotine replacement therapy who benefit less from pharmacotherapy and may need addi- (NRT) on demand for cigarettes on quit day among smokers tional treatment resources. with substance use disorders (SUD) and to determine whether Trial registration https://clinicaltrials.gov/ct2/show/ reduced demand was associated with subsequent abstinence NCT00756275 from smoking at 1 and 3 months. Methods Participants (N = 110) were randomized to double- . . blind, double-placebo conditions: VAR with placebo NRT or Keywords Smoking Nicotine dependence Behavioral . . . economics Varenicline Nicotine replacement therapy NRTwith placebo capsules. The cigarette purchase task (CPT) . . was used to assess demand for cigarettes at baseline and on Cigarette purchase task Substance use disorders Abstinence quit day, following a 1-week medication dose run-up/placebo capsule lead-in and http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Psychopharmacology Springer Journals

Effects of varenicline versus transdermal nicotine replacement therapy on cigarette demand on quit day in individuals with substance use disorders

Loading next page...
 
/lp/springer_journal/effects-of-varenicline-versus-transdermal-nicotine-replacement-therapy-LbXB5bX0tZ
Publisher
Springer Berlin Heidelberg
Copyright
Copyright © 2017 by Springer-Verlag Berlin Heidelberg
Subject
Biomedicine; Neurosciences; Pharmacology/Toxicology; Psychiatry
ISSN
0033-3158
eISSN
1432-2072
D.O.I.
10.1007/s00213-017-4635-4
Publisher site
See Article on Publisher Site

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial